Magnetic resonance imaging is a valuable tool to evaluate the therapeutic efficacy of burosumab in children with X-linked hypophosphatemia.
Zhukouskaya VV, Mannes I, Chaussain C, Kamenický P, Audrain C, Lambert AS, Nevoux J, Wicart P, Briot K, Di Rocco F, Trabado S, Prié D, Di Somma C, Colao A, Adamsbaum C, Rothenbuhler A, Linglart A.
Zhukouskaya VV, et al. Among authors: mannes i.
Eur J Endocrinol. 2021 Aug 27;185(4):475-484. doi: 10.1530/EJE-21-0429.
Eur J Endocrinol. 2021.
PMID: 34292170
Clinical Trial.